BCDA - BioCardia, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 531.92M
Enterprise Value 323.64M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)65.27
Price/Book (mrq)N/A
Enterprise Value/Revenue 348.34
Enterprise Value/EBITDA 6-1.62

Trading Information

Stock Price History

Beta (3Y Monthly) 2.57
52-Week Change 3-61.88%
S&P500 52-Week Change 31.11%
52 Week High 332.2200
52 Week Low 34.3200
50-Day Moving Average 39.5421
200-Day Moving Average 310.8414

Share Statistics

Avg Vol (3 month) 33.14k
Avg Vol (10 day) 311.9k
Shares Outstanding 54.85M
Float 2.26M
% Held by Insiders 167.63%
% Held by Institutions 10.11%
Shares Short (Mar 11, 2003) 412
Short Ratio (Mar 11, 2003) 40
Short % of Float (Mar 11, 2003) 4N/A
Short % of Shares Outstanding (Mar 11, 2003) 40.00%
Shares Short (prior month Jan 10, 2003) 412

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Nov 3, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,002.04%

Management Effectiveness

Return on Assets (ttm)-176.83%
Return on Equity (ttm)-829.13%

Income Statement

Revenue (ttm)489k
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)-64.00%
Gross Profit (ttm)-8.35M
EBITDA -14.59M
Net Income Avi to Common (ttm)-14.6M
Diluted EPS (ttm)-3.2010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)517k
Total Cash Per Share (mrq)0.11
Total Debt (mrq)1.37M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.28
Book Value Per Share (mrq)-0.46

Cash Flow Statement

Operating Cash Flow (ttm)-9.97M
Levered Free Cash Flow (ttm)-4.51M